CVS
CVS HEALTH CorpPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 27 to Mar 30 4 court rulings: Mona Malhotra v. CVS Health Inc., Caremark, LLC; 1:26-cv-22124 PIEDRA v. HOLIDAY CVS, L.L.C. and 2 more
- May 1 to May 15 ▲ 2 buys: Ro Khanna bought $1,001 - $15,000, last disclosed Jun 11
- May 6 ▲ CVS Health reported strong Q1 2026 results with Adjusted EPS of $2.5…
- May 8 ▼ 1 insider sell $6.2M at $89.58
- May 19 to May 21 ▼ 3 days of insider sells: $352.7M by 1 insider, avg $94.06
- Jun 30 ▲ 4 funds open new positions (13F)
- Aug 5 ▲ CVS Health reported strong Q2 2026 results with total revenues of $1…
- Oct 15 Contract: CVS Health collaborates with The Midlife Collective to red…
- Nov 4 CVS Health announced plans to separate into two independent publicly…
- Nov 4 ▲ CVS Health reported Q3 2026 revenue of $108.4B (+5.4% YoY) and Adjus…
- Nov 6 ▲ 1 insider buy $2.0M at $83.90
- Nov 13 Zimniski v. CVS Health Corp.
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $2.0M at an average $83.90. 2 insiders sold $359.0M. Price is 5% above their cost.
- InstitutionsMIXED
Q2 2026: 61 added (4 new), 47 trimmed or exited. Largest new: Viking Global Investors $379.0M, Point72 Asset Management, $202.9M.
- AnalystsBULLISH
28 of 32 rate it Buy or better.
- Short sellersSTEADY
Short interest +10.4% to 17.88M shares. 2.8 days to cover, ≈1.4% of shares.
- TrendDOWNTREND
1% below its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 2 mentions: 0 bullish, 0 bearish. No setup is alerting. Excludes 1 subscriber-only day.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | ADD | $3.5B |
| BANK OF AMERICA CORP /DE/ | DOUBLED | $2.4B |
| JPMORGAN CHASE & CO | TRIM | $2.3B |
| GQG Partners LLC | DOUBLED | $823.0M |
| RAYMOND JAMES FINANCIAL INC | ADD | $449.9M |
| WELLS FARGO & COMPANY/MN | TRIM | $380.9M |
| VIKING GLOBAL INVESTORS LP | NEW | $379.0M |
| Holocene Advisors, LP | TRIM | $310.5M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
32 analysts| Date | Firm | Rating |
|---|---|---|
| Nov 16, 2026 | 🔒 Fresh data, subscribers only MAINTAIN | |
| Nov 12, 2026 | Wells Fargo MAINTAIN | Overweight |
| Nov 5, 2026 | UBS MAINTAIN | Buy |
| Nov 5, 2026 | Leerink Partners MAINTAIN | Outperform |
| Nov 5, 2026 | Barclays MAINTAIN | Overweight |
| Oct 12, 2026 | Leerink Partners MAINTAIN | Outperform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Shah Prem S EVP and Group President Nov 6, 2026 | BUY | $2.0M |
Clark James David SVP, Cont & Chief Acct Officer Jun 26, 2026 | TAX W/H | $41.3K |
Compton-Phillips Amy EVP, Chief Medical Officer May 31, 2026 | TAX W/H | $693.1K |
Newman Brian EVP, Chief Financial Officer May 31, 2026 | TAX W/H | $225.4K |
ROBBINS LARRY Director May 21, 2026 | SELL | $34.6M |
ROBBINS LARRY Director May 21, 2026 | SELL | $35.3M |
AGUIRRE FERNANDO Director May 21, 2026 | TO ISSUER | $146.1K |
ROBBINS LARRY Director May 20, 2026 | SELL | $74.6M |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
22 filings · 3 press releases · 8 bullish · 1 bearish · 13 neutral- NEUTRAL COURT-RULINGNov 13, 2026
The U.S. government and a coalition of 29 states declined to intervene in a False Claims Act qui…
The government's declination reduces the risk of a large-scale FCA judgment, but the relator's private action remains. Monitor for any settlement or dismissal of the qui tam case; the government's…
- BULLISH INSIDER-BUYNov 6, 2026
CVS EVP and Group President Prem S. Shah purchased $2.0M of stock on the open market two days…
The purchase immediately follows a strong earnings beat and guidance raise, reinforcing management confidence. Monitor for additional insider buying in the coming weeks as a further signal.
- NEUTRAL 8-KNov 4, 2026
CVS Health announced plans to separate into two independent publicly traded companies: a…
Monitor the Form 10 registration statement filing for details on capital structure, asset allocation, and dividend policies of each entity. The separation timeline through H1 2028 means execution…
- BULLISH 8-KNov 4, 2026
CVS Health reported Q3 2026 revenue of $108.4B (+5.4% YoY) and Adjusted EPS of $2.09, above the…
The raised guidance across GAAP EPS, Adjusted EPS, and cash flow from operations signals improving operational trends, particularly in the Health Care Benefits segment's margin recovery. Monitor the…
All CVS filing & press-release reports (25)
- COURT-RULING reportNov 13, 2026
- INSIDER-BUY reportNov 6, 2026
- 8-K reportNov 4, 2026
- 8-K reportNov 4, 2026
- INST-CLUSTER reportOct 26, 2026
- PRESS-RELEASE reportOct 15, 2026
- PRESS-RELEASE reportSep 30, 2026
- 8-K reportAug 5, 2026
- PRESS-RELEASE reportJul 10, 2026
- COURT-RULING reportMay 4, 2026
- COURT-RULING reportApr 8, 2026
- COURT-RULING reportApr 8, 2026
- COURT-RULING reportJun 29, 2026
- COURT-RULING reportMar 3, 2026
- COURT-RULING reportMar 2, 2026
- COURT-RULING reportMar 2, 2026
- COURT-RULING reportApr 29, 2026
- S-3ASR reportMay 22, 2026
- COURT-RULING reportMay 19, 2026
- COURT-RULING reportMay 15, 2026
- COURT-RULING reportMar 27, 2026
- 8-K reportMay 6, 2026
- COURT-RULING reportApr 14, 2026
- COURT-RULING reportApr 14, 2026
- DEFA14A reportApr 3, 2026